Lexicon Pharmaceuticals (LXRX) Leases (2023 - 2025)
Lexicon Pharmaceuticals (LXRX) has disclosed Leases for 3 consecutive years, with $7.3 million as the latest value for Q4 2025.
- Quarterly Leases rose 51.08% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, up 51.08% year-over-year, with the annual reading at $7.3 million for FY2025, 51.08% up from the prior year.
- Leases for Q4 2025 was $7.3 million at Lexicon Pharmaceuticals, down from $7.5 million in the prior quarter.
- The five-year high for Leases was $7.5 million in Q3 2025, with the low at $4.5 million in Q2 2025.
- Average Leases over 3 years is $5.6 million, with a median of $5.3 million recorded in 2024.
- Peak annual rise in Leases hit 51.08% in 2025, while the deepest fall reached 13.96% in 2025.
- Over 3 years, Leases stood at $5.5 million in 2023, then fell by 12.53% to $4.8 million in 2024, then skyrocketed by 51.08% to $7.3 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $7.3 million, $7.5 million, and $4.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.